Stocks and InvestingStocks and Investing
Mon, February 28, 2022
Sun, February 27, 2022
Fri, February 25, 2022
Thu, February 24, 2022

Michael King Maintained (AGIO) at Strong Buy with Decreased Target to $96 on, Feb 24th, 2022


Published on 2024-10-27 19:49:31 - WOPRAI, Michael King
  Print publication without navigation


Michael King of HC Wainwright & Co., Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Strong Buy with Decreased Target from $98 to $96 on, Feb 24th, 2022.

Michael has made no other calls on AGIO in the last 4 months.



There are 3 other peers that have a rating on AGIO. Out of the 3 peers that are also analyzing AGIO, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrew Berens of "SVB Leerink" Maintained at Hold with Decreased Target to $30 on, Tuesday, February 22nd, 2022


These are the ratings of the 2 analyists that currently disagree with Michael


  • John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $44 on, Wednesday, February 16th, 2022
  • Greg Harrison of "B of A Securities" Initiated at Strong Buy and Held Target at $54 on, Friday, December 3rd, 2021